The Patent Finder

The Doshisha

35 patents currently held · Updated Nov 22, 2026
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 4 name spellings.

1
Ending by 2030
Jan 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Feb 13 to 22, 2027 · next Feb 13
  • 2 fees due Apr 3, 2027
  • 1 fee due May 19, 2027
    The maintenance fee for Liquid-crystal varifocal lens and focal length control method (US 10,481,429) comes due May 19, 2027. Unpaid by Nov 19, 2027, it lapses early.
  • 1 fee due Jul 2, 2027
    The maintenance fee for Composition or method including (t)ew-7197 for treating or preventing corneal endothelial diseases (US 11,857,544) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
  • 2 fees due Sep 5 to 26, 2027 · next Sep 5

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 24, 2026
  • 2 terms have ended since Aug 24, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,696,580Arteriosclerosis Evaluating Apparatus
In force
 · High confidence
In forceHigh confidence
US 8,951,401Method for Electrochemically Depositing Carbon Film on a Substrate
In force
 · High confidence
In forceHigh confidence
US 9,555,028Drug for preventing/treating ocular disease
In force
 · USPTO record
In forceUSPTO record
US 11,730,722Corneal Endothelium Ecm Therapeutic Medicaments
In force
 · High confidence
In forceHigh confidence
US 10,174,284Medium, for Culturing Corneal Endothelial Cells, Containing Conditioned Medium from Mesenchymal Stem Cells
In force
 · High confidence
In forceHigh confidence
US 11,382,904Therapeutic Drug for Diseases Related to Endoplasmic Reticulum Cell Death in Corneal Endothelium
In force
 · High confidence
In forceHigh confidence
US 12,788,747Therapeutic Drug for Diseases Related to Endoplasmic Reticulum Cell Death in Corneal Endothelium
In force
 · High confidence
In forceHigh confidence
US 10,813,920Drug for treating corneal endothelium by promoting cell proliferation or inhibiting cell damage
In force
 · USPTO record
In forceUSPTO record
US 11,918,630Treatment of Retina and Nerve Using Laminin
In force
 · High confidence
In forceHigh confidence
US 11,633,477Novel Treatment of Cornea Using Laminin
In force
 · High confidence
In forceHigh confidence
10 of 35 patents shown.
Pro members see all 35.
Pro members: see all 35 patents
Also on record, not counted in the 35: 4 patents in force now held by others · 51 lapsed for an unpaid fee · 1 ended at full term · 1 past the fee grace period. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

10 pending · 11 abandoned · 27 no status recorded

Showing 1 to 10 of 48, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/306,993Method for Producing Metal Carbide, Method for Producing Hydrocarbon, and Metal Carbide CompositionAug 21, 2025Pending
18/330,510Corneal Endothelium Ecm Therapeutic MedicamentsJun 7, 2023Pending
18/852,996Corneal Endothelial Cell Preparation Containing No Culture-Derived Component, and Method for Producing SameMar 30, 2023Pending
18/709,962Nov 14, 2022No status recorded
18/708,876Cryopreservation Preparation for Corneal Endothelial Cells and Method for Producing Said Cryopreservation PreparationNov 10, 2022Pending
18/287,183Carbon Carrier for Fuel Cell Catalyst and Fuel Cell CatalystOct 24, 2022Pending
18/702,178Oct 14, 2022No status recorded
18/276,756Method for Producing Carbon MaterialFeb 14, 2022Pending
18/252,191Electrode and Method of Producing the Same, and Electrochemical Device Using the SameNov 9, 2021Pending
18/039,569Gold-Supported Carbon Catalyst and Method for Manufacturing SameNov 8, 2021Pending
10 of 48 applications shown.
Pro members see all 48 published applications.
Pro members: see all 48 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited